RGD Reference Report - Uncoupling protein downregulation in doxorubicin-induced heart failure improves mitochondrial coupling but increases reactive oxygen species generation. - Rat Genome Database

Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   

Uncoupling protein downregulation in doxorubicin-induced heart failure improves mitochondrial coupling but increases reactive oxygen species generation.

Authors: Bugger, H  Guzman, C  Zechner, C  Palmeri, M  Russell, KS  Russell RR, 3RD 
Citation: Bugger H, etal., Cancer Chemother Pharmacol. 2011 Jun;67(6):1381-8. doi: 10.1007/s00280-010-1441-7. Epub 2010 Aug 31.
RGD ID: 7204424
Pubmed: PMID:20809120   (View Abstract at PubMed)
PMCID: PMC3051028   (View Article at PubMed Central)
DOI: DOI:10.1007/s00280-010-1441-7   (Journal Full-text)

PURPOSE: Doxorubicin-based chemotherapy is limited by the development of dose-dependent left ventricular dysfunction and congestive heart failure caused by reactive oxygen species (ROS). Uncoupling proteins (UCP) can inhibit mitochondrial ROS production as well as decrease myocyte damage from exogenous ROS. Prior studies have shown that cardiac UCP2 and UCP3 mRNA expression is decreased with acute doxorubicin treatment. However, the expression of UCP protein in hearts with doxorubicin cardiotoxicity and the resultant changes in mitochondrial function and oxidant stress have not been determined. METHODS: Heart failure was induced in Sprague-Dawley rats with intraperitoneal injections of doxorubicin (2 mg/kg t.i.w., total dose: 18 mg/kg). Mitochondria were isolated from mice receiving doxorubicin or saline injections for determination of UCP2 and UCP3 expression. In addition, mitochondrial respiration, ATP synthesis and ROS production were determined. RESULTS: Doxorubicin-induced heart failure was associated with significant decreases in UCP2 and UCP3 protein expression compared with nonfailing hearts (P < 0.05). While the rates of state 3 and state 4 respiration and ATP synthesis were lower in mitochondria isolated from failing hearts, the respiratory control ratio was 15% higher (P < 0.05), and the ratio of ATP production to oxygen consumption was 25% higher (P < 0.05) in mitochondria from failing hearts, indicating greater coupling between citric acid cycle flux and mitochondrial ATP synthesis. However, the decrease in UCP expression was associated with 50% greater mitochondrial ROS generation (P < 0.05). CONCLUSIONS: Downregulation of myocardial UCP2 and UCP3 in the setting of doxorubicin-induced heart failure is associated with improved efficiency of ATP synthesis, which might compensate for abnormal energy metabolism. However, this beneficial effect is counterbalanced by greater oxidant stress.

RGD Manual Disease Annotations    Click to see Annotation Detail View
TermQualifierEvidenceWithReferenceNotesSourceOriginal Reference(s)
congestive heart failure  ISOUcp2 (Rattus norvegicus)7204424; 7204424protein:decreased expression:heart and mitochondriaRGD 
congestive heart failure  ISOUcp3 (Rattus norvegicus)7204424; 7204424protein:decreased expression:heart and mitochondriaRGD 
congestive heart failure  IEP 7204424; 7204424protein:decreased expression:heart and mitochondriaRGD 

Objects Annotated

Genes (Rattus norvegicus)
Ucp2  (uncoupling protein 2)
Ucp3  (uncoupling protein 3)

Genes (Mus musculus)
Ucp2  (uncoupling protein 2 (mitochondrial, proton carrier))
Ucp3  (uncoupling protein 3 (mitochondrial, proton carrier))

Genes (Homo sapiens)
UCP2  (uncoupling protein 2)
UCP3  (uncoupling protein 3)


Additional Information